These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1380044)
1. Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis. Myers LK; Terato K; Seyer JM; Stuart JM; Kang AH J Immunol; 1992 Aug; 149(4):1439-43. PubMed ID: 1380044 [TBL] [Abstract][Full Text] [Related]
2. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. Myers LK; Seyer JM; Stuart JM; Terato K; David CS; Kang AH J Immunol; 1993 Jul; 151(1):500-5. PubMed ID: 7686947 [TBL] [Abstract][Full Text] [Related]
3. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis. Myers LK; Rosloniec EF; Seyer JM; Stuart JM; Kang AH J Immunol; 1993 May; 150(10):4652-8. PubMed ID: 8482852 [TBL] [Abstract][Full Text] [Related]
4. Type II collagen in cartilage evokes peptide-specific tolerance and skews the immune response. Malmström V; Kjellén P; Holmdahl R J Autoimmun; 1998 Jun; 11(3):213-21. PubMed ID: 9693969 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice. Brand DD; Myers LK; Terato K; Whittington KB; Stuart JM; Kang AH; Rosloniec EF J Immunol; 1994 Mar; 152(6):3088-97. PubMed ID: 7511638 [TBL] [Abstract][Full Text] [Related]
6. Restricted TCR V alpha repertoire in the T cell response to a tolerogenic determinant of type II collagen. Kawamura S; Miyahara H; Esaki Y; Myers LK; Rosloniec EF; Stuart JM; Kang AH J Immunol; 1997 Jun; 158(12):6013-8. PubMed ID: 9190956 [TBL] [Abstract][Full Text] [Related]
7. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis. Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881 [TBL] [Abstract][Full Text] [Related]
9. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis. Chu CQ; Londei M J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020 [TBL] [Abstract][Full Text] [Related]
10. Epitope specificity and T cell receptor usage in type II collagen induced autoimmune ear disease. Yoo TJ; Lee MK; Min YS; Chiang HJ; Wang K; Fujiyoshi T; Watanabe T; Krug MS; Seyer J; Cheng KC Cell Immunol; 1994 Aug; 157(1):249-62. PubMed ID: 7518752 [TBL] [Abstract][Full Text] [Related]
11. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Michaëlsson E; Andersson M; Engström A; Holmdahl R Eur J Immunol; 1992 Jul; 22(7):1819-25. PubMed ID: 1378019 [TBL] [Abstract][Full Text] [Related]
12. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis. Rosloniec EF; Whittington KB; Brand DD; Myers LK; Stuart JM Cell Immunol; 1996 Aug; 172(1):21-8. PubMed ID: 8806802 [TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a tolerogenic T cell determinant within residues 181-209 of chick type II collagen. Myers LK; Cooper SW; Terato K; Seyer JM; Stuart JM; Kang AH Clin Immunol Immunopathol; 1995 Apr; 75(1):33-8. PubMed ID: 7533683 [TBL] [Abstract][Full Text] [Related]
14. Characterization of signal transduction through the TCR-zeta chain following T cell stimulation with analogue peptides of type II collagen 260-267. Tang B; Myers LK; Rosloniec EF; Whittington KB; Stuart JM; Kang AH J Immunol; 1998 Apr; 160(7):3135-42. PubMed ID: 9531268 [TBL] [Abstract][Full Text] [Related]
15. Prevention of experimental autoimmune arthritis with a peptide fragment of type II collagen. Ku G; Kronenberg M; Peacock DJ; Tempst P; Banquerigo ML; Braun BS; Reeve JR; Brahn E Eur J Immunol; 1993 Mar; 23(3):591-9. PubMed ID: 7680609 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the antigenic structure of human type II collagen. Krco CJ; Pawelski J; Harders J; McCormick D; Griffiths M; Luthra HS; David CS J Immunol; 1996 Apr; 156(8):2761-8. PubMed ID: 8609394 [TBL] [Abstract][Full Text] [Related]
17. Molecular definition and characterization of recombinant bovine CB8 and CB10: immunogenicity and arthritogenicity. Tang B; Chiang TM; Brand DD; Gumanovskaya ML; Stuart JM; Kang AH; Myers LK Clin Immunol; 1999 Sep; 92(3):256-64. PubMed ID: 10479530 [TBL] [Abstract][Full Text] [Related]
18. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice. Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744 [TBL] [Abstract][Full Text] [Related]
19. Structural requirements for recognition of a type II collagen peptide by murine T cell hybridomas. Lambert LE; Berling JS Cell Immunol; 1994 Jan; 153(1):171-83. PubMed ID: 7506999 [TBL] [Abstract][Full Text] [Related]
20. A novel recombinant peptide containing only two T-cell tolerance epitopes of chicken type II collagen that suppresses collagen-induced arthritis. Xi C; Tan L; Sun Y; Liang F; Liu N; Xue H; Luo Y; Yuan F; Sun Y; Xi Y Mol Immunol; 2009 Feb; 46(4):729-37. PubMed ID: 19041137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]